186 related articles for article (PubMed ID: 28031228)
1. Reprogramming Medulloblastoma-Propagating Cells by a Combined Antagonism of Sonic Hedgehog and CXCR4.
Ward SA; Warrington NM; Taylor S; Kfoury N; Luo J; Rubin JB
Cancer Res; 2017 Mar; 77(6):1416-1426. PubMed ID: 28031228
[TBL] [Abstract][Full Text] [Related]
2. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
[TBL] [Abstract][Full Text] [Related]
3. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
[TBL] [Abstract][Full Text] [Related]
4. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.
Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ
Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898
[TBL] [Abstract][Full Text] [Related]
5. Overcoming resistance to Sonic Hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma.
Pambid MR; Berns R; Adomat HH; Hu K; Triscott J; Maurer N; Zisman N; Ramaswamy V; Hawkins CE; Taylor MD; Dunham C; Guns E; Dunn SE
Pediatr Blood Cancer; 2014 Jan; 61(1):107-15. PubMed ID: 23940083
[TBL] [Abstract][Full Text] [Related]
6. Potential use of CXCL12/CXCR4 and sonic hedgehog pathways as therapeutic targets in medulloblastoma.
Amarante MK; Vitiello GAF; Rosa MH; Mancilla IA; Watanabe MAE
Acta Oncol; 2018 Sep; 57(9):1134-1142. PubMed ID: 29771176
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma.
Sengupta R; Dubuc A; Ward S; Yang L; Northcott P; Woerner BM; Kroll K; Luo J; Taylor MD; Wechsler-Reya RJ; Rubin JB
Cancer Res; 2012 Jan; 72(1):122-32. PubMed ID: 22052462
[TBL] [Abstract][Full Text] [Related]
8. Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.
Yuan L; Zhang H; Liu J; Rubin JB; Cho YJ; Shu HK; Schniederjan M; MacDonald TJ
Mol Cancer; 2013 Mar; 12():18. PubMed ID: 23497290
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells.
Elamin MH; Shinwari Z; Hendrayani SF; Al-Hindi H; Al-Shail E; Khafaga Y; Al-Kofide A; Aboussekhra A
Mol Carcinog; 2010 Mar; 49(3):302-14. PubMed ID: 20025076
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
[TBL] [Abstract][Full Text] [Related]
11. SHH inhibitors for the treatment of medulloblastoma.
Samkari A; White J; Packer R
Expert Rev Neurother; 2015; 15(7):763-70. PubMed ID: 26027634
[TBL] [Abstract][Full Text] [Related]
12. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
Purzner T; Purzner J; Buckstaff T; Cozza G; Gholamin S; Rusert JM; Hartl TA; Sanders J; Conley N; Ge X; Langan M; Ramaswamy V; Ellis L; Litzenburger U; Bolin S; Theruvath J; Nitta R; Qi L; Li XN; Li G; Taylor MD; Wechsler-Reya RJ; Pinna LA; Cho YJ; Fuller MT; Elias JE; Scott MP
Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206138
[TBL] [Abstract][Full Text] [Related]
13. CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model.
Tan IL; Arifa RDN; Rallapalli H; Kana V; Lao Z; Sanghrajka RM; Sumru Bayin N; Tanne A; Wojcinski A; Korshunov A; Bhardwaj N; Merad M; Turnbull DH; Lafaille JJ; Joyner AL
Oncogene; 2021 Jan; 40(2):396-407. PubMed ID: 33159168
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
[TBL] [Abstract][Full Text] [Related]
15. HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma.
Bell JB; Rink JS; Eckerdt F; Clymer J; Goldman S; Thaxton CS; Platanias LC
Sci Rep; 2018 Jan; 8(1):1211. PubMed ID: 29352211
[TBL] [Abstract][Full Text] [Related]
16. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM
Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541
[TBL] [Abstract][Full Text] [Related]
17. ATOH1 Promotes Leptomeningeal Dissemination and Metastasis of Sonic Hedgehog Subgroup Medulloblastomas.
Grausam KB; Dooyema SDR; Bihannic L; Premathilake H; Morrissy AS; Forget A; Schaefer AM; Gundelach JH; Macura S; Maher DM; Wang X; Heglin AH; Ge X; Zeng E; Puget S; Chandrasekar I; Surendran K; Bram RJ; Schüller U; Talyor MD; Ayrault O; Zhao H
Cancer Res; 2017 Jul; 77(14):3766-3777. PubMed ID: 28490517
[TBL] [Abstract][Full Text] [Related]
18. Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes.
Yoon JW; Gilbertson R; Iannaccone S; Iannaccone P; Walterhouse D
Int J Cancer; 2009 Jan; 124(1):109-19. PubMed ID: 18924150
[TBL] [Abstract][Full Text] [Related]
19. Neogenin1 is a Sonic Hedgehog target in medulloblastoma and is necessary for cell cycle progression.
Milla LA; Arros A; Espinoza N; Remke M; Kool M; Taylor MD; Pfister SM; Wainwright BJ; Palma V
Int J Cancer; 2014 Jan; 134(1):21-31. PubMed ID: 23775842
[TBL] [Abstract][Full Text] [Related]
20. RNF220 is required for cerebellum development and regulates medulloblastoma progression through epigenetic modulation of Shh signaling.
Ma P; An T; Zhu L; Zhang L; Wang H; Ren B; Sun B; Zhou X; Li Y; Mao B
Development; 2020 Jun; 147(21):. PubMed ID: 32376680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
